Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon contact icon menu icon
Medicilon Logo
|
search icon close search icon contact icon menu icon
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
FAQs

What is the Main Difference Between siRNA and ASO?

1. The chemical structure

  ASO is single-stranded, and siRNA is double-stranded

2. Mechanism of action

  ASO either degrades target mRNA through RNase H, interferes mRNA function via steric effects or affects mRNA shearing, or acts on miRNA

  siRNA degrades mRNA primarily through RISC

3. The cellular space where the drug is exerted

  RNase H is present in both cytoplasm and nucleus, allowing ASO to function in both compartments. However, RISC is only present in the cytoplasm, limiting siRNA’s action to this space.

4. Duration of action and whether it can be amplified

  RISC can repeatedly target mRNA; prolonging the effect of siRNA.

  The released sense strand of siRNA can be degraded or serve as a primer for dsRNA amplification via RNA-dependent RNA polymerase, using target mRNA as a template. Dicer processes dsRNA into siRNA, initiating an amplified RNAi cycle. As a result, the drug effect is amplified in a cascading manner.

5. Safety/Toxicity

  ASO generally exhibits higher toxicity compared to siRNA, particularly liver and kidney toxicity. ASO also poses a risk of thrombocytopenia, likely linked to its structure and mechanism of action.